Showing results (1-10 of 122) with videos related to
Sort By:
Pageof 13
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 13, 2002
Biomarkers in psychotropic drug developmentSaeeduddin Ahmed, P David Mozley, William Z PotterAnnals of General Psychiatry|January 27, 2009
An analysis of correlations among four outcome scales employed in clinical trials of patients with major depressive disorderQin Jiang, Saeeduddin AhmedMolecular Imaging and Biology|May 25, 2005
Weaving single photon imaging into new drug developmentP David MozleyExpert Review of Clinical Pharmacology|December 25, 2014
Optimizing early Go/No Go decisions in CNS drug developmentWilliam Z PotterAdvances in Neurobiology|November 19, 2024
Public-Private Partnerships for Neuropsychiatric Drug Development: A PerspectiveWilliam Z PotterJournal of Clinical Psychopharmacology|October 17, 2022
Better Approaches to Derisking Psychiatric Drug Development are Needed, Not New Funding MechanismsWilliam Z PotterThe Journal of Clinical Investigation|August 28, 2012
Mining the secrets of the CSF: developing biomarkers of neurodegenerationWilliam Z PotterCNS Spectrums|September 7, 2007
Analysis of the rate of improvement of specific psychic and somatic symptoms of general anxiety disorder during long-term treatment with venlafaxine ERStephen M Stahl, Saeeduddin Ahmed, Vincent HaudiquetPrimary Care Companion to the Journal of Clinical Psychiatry|September 14, 2004
The Metabolic Syndrome in Patients With Severe Mental IllnessesPatrick Toalson, Saeeduddin Ahmed, Thomas Hardy, et al.Journal of Clinical Psychopharmacology|April 30, 2022
Central Nervous System Trial Failures: Using the Fragile X Syndrome-mGluR5 Drug Target to Highlight the Complexities of Translating Preclinical Discoveries Into Human TrialsMargaret C Grabb, William Z PotterPageof 13